Disease Biology

5:06
New insights in the biology of myeloproliferative neoplasms
Anna Rita Migliaccio
3:19
Finding novel targets for myelofibrosis from animal models
Anna Rita Migliaccio
5:35
Genetic profiling of multiple myeloma in the novel agents era
Niccolo Bolli
2:34
Evolving treatment landscape of DLBCL
Gerardo Musuraca
2:42
Optimizing biological agents for ALL
Francesco Lanza
2:19
Italian perspective: managing DLBCL
Gerardo Musuraca
4:51
Localized amyloidosis: symptoms and site of disease
Eli Muchtar
4:01
AL amyloidosis: multidisciplinary treatment approach
Efstathios Kastritis
3:04
AL amyloidosis during the pandemic
Efstathios Kastritis
2:00
AL amyloidosis: Hot topics from ISA 2020
Vaishali Sanchorawala
2:20
New prognostic markers in AL amyloidosis
Efstathios Kastritis
4:05
Post-renal transplantation hematological response assessment: AL amyloidosis
Oliver Charles Cohen
2:23
The use of solid organ transplant in AL amyloidosis
Efstathios Kastritis
11:33
Treatment algorithm for low-risk MDS
Valeria Santini
1:10
The pathways of CLL pathogenesis and CLL’s relationship with MBL
Kostas Stamatopoulos
1:44
Immunoglobulins and microenvironmental triggers in CLL pathogenesis
Kostas Stamatopoulos
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals